Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: A randomized comparison

BJU International

Volumn 101, Issue 9, 2008, Pages 1106-1110

  Van Der Aa, Madelon N M ^a   Steyerberg, Ewout W ^a   Sen, E Fatma ^a   Zwarthoff, Ellen C ^a   Kirkels, Wim J ^a   Van Der Kwast, Theo H ^a   Essink Bot, Marie Louise ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cysto urethroscopy; Non muscle invasive bladder cancer; Patients' experiences; Quality of life; Questionnaire; Surveillance

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; BLADDER DISCOMFORT; CANCER GRADING; CANCER SCREENING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTOSCOPY; DYSURIA; EXPERIENCE; FEMALE; FEVER; GENETIC ANALYSIS; HEMATURIA; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE ANALYSIS; MOTIVATION; NON INVASIVE MEASUREMENT; PAIN; PAIN ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADAPTATION, PSYCHOLOGICAL; AGED; ATTITUDE TO HEALTH; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; PAIN; PATIENT SATISFACTION; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRES; URINARY BLADDER NEOPLASMS;

EID: 41849105441     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07224.x     Document Type: Article

References (22)

1. Sengupta N, Siddiqui E, Mumtaz FH. Cancers of the bladder. J R Soc Health 2004 124 : 228 9
2. Allard P, Bernard P, Fradet Y, Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998 81 : 692 8
3. Kurth KH, Denis L, Bouffioux C et al. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 1995 31A : 1840 6
4. Witjes JA, Melissen DO, Kiemeney LA. Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey. Eur Urol 2006 49 : 478 84
5. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003 21 : 1315 30
6. Wright MP, Jones DJ. Surveillance for bladder cancer. the management of 4.8 million people. South-west Urologists. BJU Int 2000 85 : 431 3
7. Mariappan P, Smith G. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J Urol 2005 173 : 1108 11
8. Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995 33 : 828 41
9. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005 47 : 736 48
10. van Rhijn BW, Lurkin I, Kirkels WJ, van der Kwast TH, Zwarthoff EC. Microsatellite analysis - DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer 2001 92 : 768 75
11. Amira N, Mourah S, Rozet F et al. Non-invasive molecular detection of bladder cancer recurrence. Int J Cancer 2002 101 : 293 7
12. Vriesema JL, Poucki MH, Kiemeney LA, Witjes JA. Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis. Urology 2000 56 : 793 7
13. Muezzinoglu T, Ceylan Y, Temeltas G, Lekili M, Buyuksu C. Evaluation of pain caused by urethrocystoscopy in patients with superficial bladder cancer: a perspective of quality of life. Onkologie 2005 28 : 260 4
14. Kortmann BB, Sonke GS, D'Ancona FC, Floratos DL, Debruyne FM, De La Rosette JJ. The tolerability of urodynamic studies and flexible cysto-urethroscopy used in the assessment of men with lower urinary tract symptoms. BJU Int 1999 84 : 449 53
15. Denholm SW, Conn IG, Newsam JE, Chisholm GD. Morbidity following cystoscopy: comparison of flexible and rigid techniques. Br J Urol 1990 66 : 152 4
16. Herr HW, Schneider M. Outpatient flexible cystoscopy in men. a randomized study of patient tolerance. J Urol 2001 165 : 1971 2
17. Mao L, Schoenberg MP, Scicchitano M et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 1996 271 : 659 62
18. Kruijshaar ME, Kerkhof M, Siersema PD, Steyerberg EW, Homs MY, Essink-Bot ML. The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. Endoscopy 2006 38 : 873 8
19. Essink-Bot ML, de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schroder FH. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 1998 90 : 925 31
20. Essink-Bot ML, Rijnsburger AJ, van Dooren S, de Koning HJ, Seynaeve C. Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition. Breast 2006 15 : 673 6
21. Nijs HG, Essink-Bot ML, DeKoning HJ, Kirkels WJ, Schroder FH. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med 2000 22 : 312 6
22. Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. Urology 2005 65 : 290 4